Product Information

METHYLPHENIDATE ER 18 MG TAB is a generic product labeled by American Health Packaging, priced at $0.6038 per EA under NDC 60687053221. Its NADAC has been published 275 times since Aug 12, 2020.

FDA first approved this application on Sep 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER 18 MG TAB

Methylphenidate Hydrochloride
$0.6038per EA
DEA Schedule CII

Strength

18 mg/1

NDC

60687053221

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211009

FDA Approved

9/3/2019

TE Code

AB

On Market Since

6/25/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 18 MG TAB has been published 275 times since Aug 12, 2020, and over the history we have for it it has declined 67.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6038 per EA
All-time high$2.1648 (Sep 16, 2020)
All-time low$0.5230 (Jul 20, 2022)
52-week high$0.6751
52-week low$0.5758
Median price$0.7051
Average price$0.8143
Largest weekly change-44.5% (Sep 20, 2023)
Weeks tracked275
Tracking sinceAug 12, 2020

Price History

1W

-1.0%

1M

+4.8%

3M

+4.9%

6M

-2.3%

1Y

-10.6%

3Y

-15.3%

5Y

-3.3%

All

-67.0%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 18 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 18 MG TAB, manufactured by American Health Packaging, is $0.6038 per EA (NDC 60687053221), effective Nov 18, 2026.

How has the price of METHYLPHENIDATE ER 18 MG TAB changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 18 MG TAB has declined 67.0%. It has been tracked across 275 weekly CMS publications since Aug 12, 2020.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 18 MG TAB?

Since Aug 12, 2020, the NADAC for METHYLPHENIDATE ER 18 MG TAB has ranged from a low of $0.5230 (Jul 20, 2022) to a high of $2.1648 (Sep 16, 2020), with a median of $0.7051 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 18 MG TAB?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 18 MG TAB, is $0.5758 per EA — about 5% below METHYLPHENIDATE ER 18 MG TAB.

Who manufactures METHYLPHENIDATE ER 18 MG TAB?

METHYLPHENIDATE ER 18 MG TAB (NDC 60687053221) is labeled by American Health Packaging, and CMS classifies it as a generic product.